• Targeting the MYC Axis: 10074-G5’s Strategic Power in Transl

  2026-07-09

  This thought-leadership article explores how 10074-G5, a small-molecule c-Myc inhibitor, enables translational researchers to strategically dissect the oncogenic c-Myc/Max axis. By integrating mechanistic insights—including the MYC/TERT/NFκB signaling loop implicated in cancer aggressiveness—this piece provides actionable protocol guidance, evidence-driven context, and a forward-looking outlook for apoptosis, cell cycle, and tumor regression studies, with a focus on clinical translation.

• O-propargyl-puromycin (OPP): Redefining Protein Synthesis Qu

  2026-07-08

  Unlock the full potential of O-propargyl-puromycin (OPP) for precise protein synthesis measurement in cells. This in-depth analysis explores advanced assay optimization, mechanistic insights, and practical implications for immunology and proteomics research.

• Phenothiazines Enhance Macrophage Antibacterial Defense via

  2026-07-08

  This study demonstrates that phenothiazines, including perphenazine, significantly boost macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy. These findings reveal a host-directed therapeutic strategy to counteract intracellular bacterial infections and advance research into antimicrobial resistance.

• Filipin III: Advancing Cholesterol Detection for Translation

  2026-07-07

  This thought-leadership article explores how Filipin III, a polyene macrolide antibiotic, is redefining cholesterol detection in biological membranes. Integrating mechanistic insight, strategic guidance, and translational relevance, we examine the unique utility of Filipin III in visualizing cholesterol microdomains, validate its critical role using recent immunometabolic findings, and offer a forward-looking perspective for researchers seeking to bridge mechanistic discovery and therapeutic innovation.

• Bifidobacterium Modulates Neuroinflammation in Chronic HE Ra

  2026-07-07

  This study demonstrates that Bifidobacterium, but not fecal microbiota transplantation (FMT), significantly inhibits neuroinflammation in a rat model of chronic hepatic encephalopathy (HE), as visualized by [18F]PBR146 PET imaging. The work advances noninvasive monitoring of gut-mediated interventions and highlights the complexity of microbiota–brain interactions in HE.

• G-15: G Protein-Coupled Estrogen Receptor Antagonist Workflo

  2026-07-06

  G-15 stands out as a highly selective G protein-coupled estrogen receptor antagonist, empowering researchers to dissect GPR30 signaling with precision in immune, neurobiological, and cell signaling contexts. This article delivers actionable protocol enhancements, troubleshooting strategies, and practical insights that translate recent reference breakthroughs into assay-ready workflows.

• Amplex Red: High-Fidelity ROS Detection & Enzymatic Assays

  2026-07-06

  Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) stands at the forefront of reactive oxygen species detection, offering unmatched sensitivity for hydrogen peroxide and peroxidase activity assays. Explore how APExBIO’s high-purity formulation enables scalable workflows and robust troubleshooting for oxidative stress, redox signaling, and single-enzyme biosensors.

• Hydroxychloroquine Sulfate for Autoimmune Disease Research W

  2026-07-05

  Hydroxychloroquine Sulfate (SKU B4874) is designed for precise inhibition of autophagy and TLR7/9 signaling in autoimmune disease research, including systemic lupus erythematosus and rheumatoid arthritis models. It is optimized for aqueous-based, short-term protocols, and should not be used when organic solvent compatibility or long-term solution storage is required.

• Ranolazine: Anti-Ischemic Agent Mechanisms & Research Benchm

  2026-07-04

  Ranolazine is a high-purity anti-ischemic agent that inhibits late sodium currents in cardiac cells and promotes glucose oxidation, providing measurable benefits for myocardial relaxation and metabolic efficiency. Its unique dual mechanism is validated by both peer-reviewed data and APExBIO’s rigorous quality controls, supporting advanced cardiac ischemia research.

• HyperScript III RT SuperMix: Reliable qPCR for Low-Abundance

  2026-07-03

  HyperScript III RT SuperMix empowers high-fidelity cDNA synthesis from low-concentration and high-GC content RNA, revolutionizing biomarker detection in challenging cancer samples. Its integrated gDNA wiper ensures precise gene expression analysis by qPCR, as demonstrated in cutting-edge colorectal cancer immunogenomics research.

• Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-07-03

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus is designed for high-yield, randomly Cy3-labeled RNA probe synthesis in research settings. It addresses practical needs in RNA probe generation for fluorescence-based applications such as in situ hybridization and Northern blotting, but is not intended for diagnostic or therapeutic workflows.

• Phosphatase Inhibitor Cocktail 3 (100X in DMSO): Technical G

  2026-07-02

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) is designed for robust inhibition of alkaline and serine/threonine phosphatases during protein extraction, preserving phosphorylation for reliable downstream phosphoprotein analysis. It should be used where precise maintenance of protein phosphorylation is critical, such as in Western blotting and kinase assays. It is not suitable for protocols where phosphatase activity measurement is intended or where DMSO-sensitive systems are involved.

• Bacitracin (B1670): Technical Parameters for Antibacterial R

  2026-07-02

  Bacitracin (B1670) is designed for research applications targeting bacterial cell wall and peptidoglycan synthesis disruption in gram-positive and gram-negative bacteria. It should be used strictly in controlled laboratory workflows, and is not intended for diagnostic or medical use.

• Hoechst 33258: Illuminating Tumor Mechanics and Genetic Hete

  2026-07-01

  Explore the unique role of Hoechst 33258 as a bis-benzimide DNA stain in advanced tumor cell mechanics and genetic heterogeneity assays. This article dives deeper into fluorescence-based analysis, integrating recent evidence on cell membrane dynamics and oncogenic signaling.

• BKT140 (BL-8040): Redefining CXCR4 Antagonism in Oncology Tr

  2026-07-01

  This thought-leadership article delivers mechanistic insight and practical guidance for translational researchers leveraging BKT140 (BL-8040), a potent CXCR4 antagonist, to advance precision oncology. Integrating evidence from recent theranostic studies and workflow innovations, we bridge foundational signaling science with next-generation assay and clinical strategies—escalating the discussion well beyond conventional product literature.

453 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page